Do Firms Purposefully Change Capital Structure? : Evidence from a Growth Shock to Pharmaceutical Firms
Year of publication: |
2018
|
---|---|
Authors: | Giambona, Erasmo |
Other Persons: | Golec, Joseph H. (contributor) ; Lopez de Silanes, Florencio (contributor) |
Publisher: |
[2018]: [S.l.] : SSRN |
Subject: | Kapitalstruktur | Capital structure | Pharmaindustrie | Pharmaceutical industry | Schock | Shock |
Extent: | 1 Online-Ressource (54 p) |
---|---|
Type of publication: | Book / Working Paper |
Language: | English |
Notes: | Nach Informationen von SSRN wurde die ursprüngliche Fassung des Dokuments April 12, 2018 erstellt |
Other identifiers: | 10.2139/ssrn.2162376 [DOI] |
Classification: | G31 - Capital Budgeting; Investment Policy ; G32 - Financing Policy; Capital and Ownership Structure |
Source: | ECONIS - Online Catalogue of the ZBW |
-
Does Financial Leverage Influence Investment Decisions? The Case of Pharmaceutical Firms in India
Kannadhasan, M., (2014)
-
Financing Constraints and the Amplification of Aggregate Downturns
Carvalho, Daniel R., (2014)
-
Leverage Shocks : Firm-Level Evidence on Debt Overhang and Investment
Cevik, Serhan, (2021)
- More ...
-
The conditional performance of REIT stock repurchases
Giambona, Erasmo, (2006)
-
Mutual fund volatility timing and management fees
Giambona, Erasmo, (2009)
-
Strategic trading in the wrong direction by a large institutional insider
Giambona, Erasmo, (2010)
- More ...